PL2313374T3 - 6-podstawione izochinoliny i izochinolinony - Google Patents

6-podstawione izochinoliny i izochinolinony

Info

Publication number: PL2313374T3
Authority: PL; Poland
Prior art keywords: isoquinolinones; substituted isoquinolines; isoquinolines; substituted
Prior art date: 2008-06-24

Application number

PL09768948T

Other languages

English (en)

Inventor

Oliver Plettenburg

Katrin Lorenz

Matthias Loehn

John Weston

Heinz-Werner Kleemann

Original Assignee

Sanofi Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2008-06-24

Filing date

2009-06-19

Publication date

2014-03-31

2009-06-19 Application filed by Sanofi Sa filed Critical Sanofi Sa

2014-03-31 Publication of PL2313374T3 publication Critical patent/PL2313374T3/pl

Links

-1 6-substituted isoquinolines Chemical class 0.000 title 1
VDBNYAPERZTOOF-UHFFFAOYSA-N isoquinolin-1(2H)-one Chemical class C1=CC=C2C(=O)NC=CC2=C1 VDBNYAPERZTOOF-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/24—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Hematology (AREA)
Neurology (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Obesity (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Reproductive Health (AREA)
Physical Education & Sports Medicine (AREA)
Gynecology & Obstetrics (AREA)
Immunology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Emergency Medicine (AREA)
Child & Adolescent Psychology (AREA)

PL09768948T 2008-06-24 2009-06-19 6-podstawione izochinoliny i izochinolinony PL2313374T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP08290605		2008-06-24
US15314509P	2009-02-17	2009-02-17
PCT/EP2009/004420 WO2009156099A1 (en)	2008-06-24	2009-06-19	6-substituted isoquinolines and isoquinolinones
EP09768948.3A EP2313374B1 (en)	2008-06-24	2009-06-19	6-substituted isoquinolines and isoquinolinones

Publications (1)

Publication Number	Publication Date
PL2313374T3 true PL2313374T3 (pl)	2014-03-31

Family

ID=40044043

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL09768948T PL2313374T3 (pl)	2008-06-24	2009-06-19	6-podstawione izochinoliny i izochinolinony

Country Status (28)

Country	Link
US (2)	US8399482B2 (pl)
EP (1)	EP2313374B1 (pl)
JP (1)	JP5714485B2 (pl)
KR (1)	KR101607090B1 (pl)
CN (1)	CN102131785B (pl)
AR (1)	AR072280A1 (pl)
AU (1)	AU2009262516B8 (pl)
BR (1)	BRPI0914735A2 (pl)
CA (1)	CA2728128C (pl)
CO (1)	CO6321249A2 (pl)
CR (1)	CR11830A (pl)
DK (1)	DK2313374T3 (pl)
DO (1)	DOP2010000392A (pl)
ES (1)	ES2436531T3 (pl)
HR (1)	HRP20131041T1 (pl)
IL (1)	IL210115A (pl)
MA (1)	MA32399B1 (pl)
MX (1)	MX2010013974A (pl)
MY (1)	MY153615A (pl)
PE (1)	PE20110054A1 (pl)
PL (1)	PL2313374T3 (pl)
PT (1)	PT2313374E (pl)
RU (1)	RU2528229C2 (pl)
SI (1)	SI2313374T1 (pl)
SV (1)	SV2010003771A (pl)
TW (1)	TWI480265B (pl)
UY (1)	UY31926A (pl)
WO (1)	WO2009156099A1 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR3017868A1 (fr)	2014-02-21	2015-08-28	Servier Lab	Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CN106467477A (zh) *	2016-08-26	2017-03-01	天津雅奥科技发展有限公司	一种合成化合物（1‑环丙基‑1‑氰基‑4‑环己酮）的新方法
EP4422626A1 (en)	2021-10-30	2024-09-04	Aneuryst, Inc	Treatments for disturbed cerebral homeostasis
EP4402129A1 (en)	2022-08-01	2024-07-24	Valo Health, Inc.	<smallcaps/>? ? ?h? ? ? ? ?process for preparing 6-substituted-1-(2)-isoquinolinones and intermediate compound

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2702600A1 (de) *	1977-01-22	1978-07-27	Thomae Gmbh Dr K	Neue aminoalkoxyphenyl-derivate
FR2485537B2 (fr)	1977-04-13	1986-05-16	Anvar	Dipyrido(4,3-b)(3,4-f)indoles, procede d'obtention, application therapeutique et compositions pharmaceutiques les contenant
WO1992002476A1 (en)	1990-07-31	1992-02-20	E.I. Du Pont De Nemours And Company	Catalytic equilibration of selected halocarbons
US5480883A (en)	1991-05-10	1996-01-02	Rhone-Poulenc Rorer Pharmaceuticals Inc.	Bis mono- and bicyclic aryl and heteroaryl compounds which inhibit EGF and/or PDGF receptor tyrosine kinase
GB9516709D0 (en)	1995-08-15	1995-10-18	Zeneca Ltd	Medicament
ZA9610741B (en)	1995-12-22	1997-06-24	Warner Lambert Co	4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
NZ334613A (en)	1996-08-12	2002-02-01	Welfide Corp	Pharmaceutical agents comprising Rho kinase inhibitor
JPH1087629A (ja)	1996-09-18	1998-04-07	Fujisawa Pharmaceut Co Ltd	新規イソキノリン誘導体、およびその医薬用途
US6362191B1 (en)	1997-08-29	2002-03-26	Zeneca Ltd.	Aminometyl oxooxazolidinyl benzene derivatives
TW575567B (en)	1998-10-23	2004-02-11	Akzo Nobel Nv	Serine protease inhibitor
GB9912701D0 (en)	1999-06-01	1999-08-04	Smithkline Beecham Plc	Novel compounds
US6541456B1 (en)	1999-12-01	2003-04-01	Isis Pharmaceuticals, Inc.	Antimicrobial 2-deoxystreptamine compounds
CA2398388A1 (en)	2000-01-20	2001-07-26	Koji Kato	Novel piperidine compound and pharmaceutical thereof
US7217722B2 (en)	2000-02-01	2007-05-15	Kirin Beer Kabushiki Kaisha	Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same
WO2001064238A2 (en)	2000-02-29	2001-09-07	Curis, Inc.	Methods and compositions for regulating adipocytes
GB0004887D0 (en)	2000-03-01	2000-04-19	Astrazeneca Uk Ltd	Chemical compounds
AR033517A1 (es)	2000-04-08	2003-12-26	Astrazeneca Ab	Derivados de piperidina, proceso para su preparacion y uso de estos derivados en la fabricacion de medicamentos
GB0013060D0 (en)	2000-05-31	2000-07-19	Astrazeneca Ab	Chemical compounds
WO2002034712A1 (en)	2000-10-27	2002-05-02	Takeda Chemical Industries, Ltd.	Process for preparing substituted aromatic compounds and intermediates therefor
JP2004520347A (ja)	2001-01-15	2004-07-08	グラクソ　グループ　リミテッド	Ｌｄｌ−受容体発現のインデューサーとしてのアリールピペリジンおよびピペラジン誘導体
SE0101038D0 (sv)	2001-03-23	2001-03-23	Astrazeneca Ab	Novel compounds
AU2002256418A1 (en)	2001-04-27	2002-11-11	Vertex Pharmaceuticals Incorporated	Inhibitors of bace
US7199147B2 (en)	2001-06-12	2007-04-03	Dainippon Sumitomo Pharma Co., Ltd.	Rho kinase inhibitors
GB0117899D0 (en)	2001-07-23	2001-09-12	Astrazeneca Ab	Chemical compounds
WO2003024450A1 (en)	2001-09-20	2003-03-27	Eisai Co., Ltd.	Methods for treating prion diseases
SE0104340D0 (sv)	2001-12-20	2001-12-20	Astrazeneca Ab	New compounds
JPWO2004009555A1 (ja) *	2002-07-22	2005-11-17	旭化成ファーマ株式会社	５−置換イソキノリン誘導体
EP1550660A1 (en)	2002-09-12	2005-07-06	Kirin Beer Kabushiki Kaisha	Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same
US20050014783A1 (en)	2003-05-29	2005-01-20	Schering Aktiengesellschaft	Use of Rho-kinase inhibitors in the treatment of aneurysm and cardiac hypertrophy
EP1638939A2 (en)	2003-06-24	2006-03-29	Neurosearch A/S	Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
JP4718467B2 (ja)	2003-09-23	2011-07-06	メルク・シャープ・エンド・ドーム・コーポレイション	イソキノリノンカリウムチャネル阻害剤
US7691879B2 (en)	2003-09-23	2010-04-06	Merck Sharp & Dohme Corp.	Isoquinoline potassium channel inhibitors
US20050067037A1 (en)	2003-09-30	2005-03-31	Conocophillips Company	Collapse resistant composite riser
EP1671962A1 (en)	2003-10-10	2006-06-21	Ono Pharmaceutical Co., Ltd.	Novel fused heterocyclic compound and use thereof
JP2007008816A (ja)	2003-10-15	2007-01-18	Ube Ind Ltd	新規イソキノリン誘導体
WO2005054202A1 (en)	2003-11-25	2005-06-16	Eli Lilly And Company	7-phenyl-isoquinoline-5-sulfonylamino derivatives as inhibitors of akt (proteinkinase b)
WO2005074535A2 (en)	2004-01-30	2005-08-18	Eisai Co., Ltd.	Cholinesterase inhibitors for spinal cord disorders
WO2005087226A1 (en)	2004-03-05	2005-09-22	Eisai Co., Ltd.	Cadasil treatment with cholinesterase inhibitors
SE0400850D0 (sv)	2004-03-30	2004-03-31	Astrazeneca Ab	Novel Compounds
US7517991B2 (en)	2004-10-12	2009-04-14	Bristol-Myers Squibb Company	N-sulfonylpiperidine cannabinoid receptor 1 antagonists
EP1899322B1 (en)	2005-06-28	2009-09-02	Sanofi-Aventis	Isoquinoline derivatives as inhibitors of rho-kinase
PT1910333E (pt)	2005-07-26	2013-08-01	Sanofi Sa	Derivados de isoquinolona substituída com piperidinilo como inibidores da rho-cinase
SI1912949T1 (sl)	2005-07-26	2011-12-30	Sanofi Sa	Cikloheksilamin izokinolonski derivati kot inhibitorji Rho-kinaze
TW200745101A (en)	2005-09-30	2007-12-16	Organon Nv	9-Azabicyclo[3.3.1]nonane derivatives
US7618985B2 (en)	2005-12-08	2009-11-17	N.V. Organon	Isoquinoline derivatives
TW200738682A (en)	2005-12-08	2007-10-16	Organon Nv	Isoquinoline derivatives
US7893088B2 (en) *	2006-08-18	2011-02-22	N.V. Organon	6-substituted isoquinoline derivatives
RU2009128688A (ru)	2006-12-27	2011-02-10	Санофи-Авентис (Fr)	Замещенные циклоалкиламином производные изохинолина и изохинолинона
JP5313919B2 (ja)	2006-12-27	2013-10-09	サノフイ	新規な置換イソキノリン及びイソキノリノン誘導体
AU2007338410B2 (en)	2006-12-27	2012-08-16	Sanofi-Aventis	Cycloalkylamine substituted isoquinoline derivatives
PT2102164E (pt)	2006-12-27	2011-01-21	Sanofi Aventis	Derivados de isoquinolina e de isoquinolinona substituída com cicloalquilamina
JP5421783B2 (ja)	2006-12-27	2014-02-19	サノフイ	Ｒｈｏキナーゼ阻害剤としての置換イソキノロン及びイソキノリノン誘導体
CA2673918C (en)	2006-12-27	2015-02-17	Sanofi-Aventis	Substituted isoquinoline and isoquinolinone derivatives
RU2457203C2 (ru)	2006-12-27	2012-07-27	Санофи-Авентис	Замещенные циклоалкиламином производные изохинолона
JP5713893B2 (ja) *	2008-06-24	2015-05-07	サノフイ	Ｒｈｏ−キナーゼ阻害剤としての置換イソキノリン類及びイソキノリノン類

2009
- 2009-06-19 JP JP2011515174A patent/JP5714485B2/ja not_active Expired - Fee Related
- 2009-06-19 PT PT97689483T patent/PT2313374E/pt unknown
- 2009-06-19 PL PL09768948T patent/PL2313374T3/pl unknown
- 2009-06-19 ES ES09768948.3T patent/ES2436531T3/es active Active
- 2009-06-19 MX MX2010013974A patent/MX2010013974A/es active IP Right Grant
- 2009-06-19 EP EP09768948.3A patent/EP2313374B1/en active Active
- 2009-06-19 CA CA2728128A patent/CA2728128C/en not_active Expired - Fee Related
- 2009-06-19 PE PE2010001192A patent/PE20110054A1/es not_active Application Discontinuation
- 2009-06-19 KR KR1020107028931A patent/KR101607090B1/ko not_active Expired - Fee Related
- 2009-06-19 AU AU2009262516A patent/AU2009262516B8/en not_active Ceased
- 2009-06-19 HR HRP20131041AT patent/HRP20131041T1/hr unknown
- 2009-06-19 RU RU2011102376/04A patent/RU2528229C2/ru not_active IP Right Cessation
- 2009-06-19 SI SI200930784T patent/SI2313374T1/sl unknown
- 2009-06-19 BR BRPI0914735A patent/BRPI0914735A2/pt not_active IP Right Cessation
- 2009-06-19 DK DK09768948.3T patent/DK2313374T3/da active
- 2009-06-19 WO PCT/EP2009/004420 patent/WO2009156099A1/en not_active Ceased
- 2009-06-19 MY MYPI2010005676A patent/MY153615A/en unknown
- 2009-06-19 CN CN200980132931.4A patent/CN102131785B/zh not_active Expired - Fee Related
- 2009-06-22 TW TW098120766A patent/TWI480265B/zh not_active IP Right Cessation
- 2009-06-22 AR ARP090102284A patent/AR072280A1/es unknown
- 2009-06-22 UY UY0001031926A patent/UY31926A/es not_active Application Discontinuation
2010
- 2010-12-07 CR CR11830A patent/CR11830A/es not_active Application Discontinuation
- 2010-12-16 US US12/970,376 patent/US8399482B2/en active Active
- 2010-12-17 MA MA33437A patent/MA32399B1/fr unknown
- 2010-12-20 IL IL210115A patent/IL210115A/en not_active IP Right Cessation
- 2010-12-20 DO DO2010000392A patent/DOP2010000392A/es unknown
- 2010-12-20 SV SV2010003771A patent/SV2010003771A/es unknown
- 2010-12-21 CO CO10160326A patent/CO6321249A2/es not_active Application Discontinuation
2012
- 2012-12-14 US US13/715,111 patent/US20130109715A1/en not_active Abandoned

Also Published As

Publication number	Publication date
UY31926A (es)	2010-01-29
RU2528229C2 (ru)	2014-09-10
RU2011102376A (ru)	2012-07-27
BRPI0914735A2 (pt)	2019-09-24
CO6321249A2 (es)	2011-09-20
DOP2010000392A (es)	2011-01-15
CN102131785B (zh)	2014-10-29
EP2313374B1 (en)	2013-09-18
MA32399B1 (fr)	2011-06-01
SI2313374T1 (sl)	2013-12-31
PT2313374E (pt)	2013-11-29
WO2009156099A8 (en)	2010-03-11
EP2313374A1 (en)	2011-04-27
SV2010003771A (es)	2011-03-15
CA2728128A1 (en)	2009-12-30
AU2009262516A1 (en)	2009-12-30
HK1158643A1 (en)	2012-07-20
MY153615A (en)	2015-02-27
AR072280A1 (es)	2010-08-18
AU2009262516A8 (en)	2014-01-30
CN102131785A (zh)	2011-07-20
ES2436531T3 (es)	2014-01-02
WO2009156099A1 (en)	2009-12-30
JP2011525510A (ja)	2011-09-22
KR101607090B1 (ko)	2016-03-29
PE20110054A1 (es)	2011-02-15
HRP20131041T1 (hr)	2013-12-06
US8399482B2 (en)	2013-03-19
US20130109715A1 (en)	2013-05-02
IL210115A0 (en)	2011-02-28
TWI480265B (zh)	2015-04-11
AU2009262516B2 (en)	2014-01-09
US20110190339A1 (en)	2011-08-04
KR20110019753A (ko)	2011-02-28
JP5714485B2 (ja)	2015-05-07
CA2728128C (en)	2016-06-07
CR11830A (es)	2011-04-04
TW201014826A (en)	2010-04-16
MX2010013974A (es)	2011-01-14
AU2009262516B8 (en)	2014-01-30
IL210115A (en)	2016-07-31
DK2313374T3 (da)	2013-12-16

Publication	Publication Date	Title
ZA201204467B (en)	2013-02-27	Substituted isoquinolinones and quinazolinones
ZA200903552B (en)	2010-04-28	Substituted isoquinoline and isoquinolinone derivatives
EP2366699A4 (en)	2012-03-14	B-SUBSTITUTED ISOCHINOLINE DERIVATIVE AND ITS USE
ZA200903555B (en)	2010-04-28	Cycloalkylamine substituted isoquinoline and isoquinolinone derivatives
ZA201005539B (en)	2011-04-28	Novel pyridinones and pyridazinones
GB2504646B (en)	2014-09-24	Multiple user identity and bridge appearance
EP2391413A4 (en)	2015-04-01	PORTS FOR TUBE ACCESS AND RELATED METHODS
IL213993A0 (en)	2011-08-31	Poly (adp-ribose) polymerase (parp) inhibitors
IL204844A0 (en)	2010-11-30	Quinolone analogs and methods related thereto
ZA201008119B (en)	2011-07-27	Substituted isoquinolines and isoquinolinones as rho kinase inhibitors
GB0808575D0 (en)	2008-06-18	Compilign and linking
IL213631A0 (en)	2011-07-31	Isoquinoline derivative
EP2231155A4 (en)	2011-09-14	Tetrahydroisoquinoline DERIVATIVES
IL210115A0 (en)	2011-02-28	6-substituted isoquinolines and isoquinolinones
GB0912744D0 (en)	2009-08-26	Methods and uses
GB0920642D0 (en)	2010-01-13	Anchor and methods
EP2486102A4 (en)	2013-08-28	SURFACE-FINISHED STRUCTURES AND CORRESPONDING METHODS
EP2344472A4 (en)	2012-11-28	ISOCHINOLINONDERIVATE
GB0813359D0 (en)	2008-08-27	Halfin and/or platerfin
IL210114A0 (en)	2011-02-28	Bi-and polycyclic substituted isoquinoline and isoquinolinone derivatives
GB0821621D0 (en)	2008-12-31	Short and open circuit security
GB0816523D0 (en)	2008-10-15	Methods and uses